Quarterly report [Sections 13 or 15(d)]

STOCKHOLDERS' EQUITY (Details - Restrcited Stock)

v3.25.2
STOCKHOLDERS' EQUITY (Details - Restrcited Stock) - $ / shares
6 Months Ended 12 Months Ended
Jun. 30, 2025
Dec. 31, 2024
Restricted Stock [Member]    
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Outstanding beginning balance
Weighted average exercise price, Outstanding beginning balance
Restricted stock forfeited
Weighted average grant date fair value per share, Restricted stock forfeited $ 5.98
Restricted stock granted 1,971,898  
Weighted average grant date fair value per share, Restricted stock granted
Outstanding ending balance 1,961,898
Weighted average exercise price, Outstanding ending balance $ 5.98
Restricted stock, vested  
Weighted average grant date fair value per share, Vested $ 5.98
Restricted stock vested (10,000)  
[custom:WeightedAverageGrantedPriceRestrictedStockVested] $ 5.98  
Restricted stock, vested 10,000  
Equity Option [Member]    
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Outstanding beginning balance 606,452 1,387,775
Weighted average exercise price, Outstanding beginning balance $ 5.29 $ 5.23
Restricted stock forfeited (141,327) (781,323)
Weighted average grant date fair value per share, Restricted stock forfeited $ 5.64
Restricted stock granted 20,000
Weighted average grant date fair value per share, Restricted stock granted $ 5.31 $ 5.17
Outstanding ending balance 485,125 606,452
Weighted average exercise price, Outstanding ending balance $ 5.30 $ 5.29
Weighted average grant date fair value per share, Vested $ 5.66 $ 5.50
Restricted stock, vested 344,915 442,445